Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Deferred Taxes: 2024-2025

Historic Deferred Taxes for Adma Biologics (ADMA) over the last 1 years, with Sep 2025 value amounting to $4.8 million.

  • Adma Biologics' Deferred Taxes was N/A to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.1 million, marking a year-over-year change of. This contributed to the annual value of $84.3 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Adma Biologics' Deferred Taxes stood at $4.8 million, which was up 196.48% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Deferred Taxes ranged from a high of $84.3 million in Q4 2024 and a low of $1.6 million during Q2 2025.
  • In the last 2 years, Adma Biologics' Deferred Taxes had a median value of $4.1 million in 2025 and averaged $23.5 million.